Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $943.72 billion, total revenue of $174.89 billion and a weighted average PE ratio of 50.64.
Market Cap
943.72B
Revenue
174.89B
Profits
18.64B
PE Ratio
50.64
Profit Margin
10.66%
Dividend Yield
0.18%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 257.57B | 1.71% | 638,256 | 47.35B |
| 2 | DHR | Danaher Corporation | 163.05B | -0.52% | 1,048,539 | 25.61B |
| 3 | NTRA | Natera, Inc. | 59.49B | 1.92% | 789,920 | 2.71B |
| 4 | A | Agilent Technologies, Inc. | 50.21B | 1.20% | 1,096,826 | 7.37B |
| 5 | WAT | Waters Corporation | 45.65B | 1.91% | 282,321 | 4.64B |
| 6 | IQV | IQVIA Holdings Inc. | 44.64B | -0.87% | 1,223,018 | 17.31B |
| 7 | IDXX | IDEXX Laboratories, Inc. | 44.38B | -1.20% | 205,065 | 4.55B |
| 8 | ILMN | Illumina, Inc. | 42.32B | 3.41% | 902,169 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 33.82B | 1.08% | 64,524 | 4.13B |
| 10 | LH | Labcorp Holdings Inc. | 26.63B | -0.46% | 414,478 | 14.35B |
| 11 | DGX | Quest Diagnostics Incorporated | 26.58B | -0.56% | 378,917 | 11.84B |
| 12 | GH | Guardant Health, Inc. | 23.72B | 2.03% | 607,417 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 18.95B | 0.10% | 92,499 | 2.84B |
| 14 | RVTY | Revvity, Inc. | 18.03B | 0.72% | 641,440 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 17.02B | -0.22% | 373,000 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 14.10B | -0.54% | 355,026 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 10.41B | -0.10% | 2,503,053 | 2.10B |
| 18 | GRAL | GRAIL, Inc. | 6.75B | 8.04% | 460,315 | 165.26M |
| 19 | RDNT | RadNet, Inc. | 5.78B | 4.81% | 582,389 | 2.27B |
| 20 | BLLN | BillionToOne, Inc. | 5.43B | 3.19% | 157,826 | 397.41M |
| 21 | SHC | Sotera Health Company | 5.27B | 0.38% | 572,002 | 1.22B |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 4.40B | 4.93% | 534,661 | 308.08M |
| 23 | VCYT | Veracyte, Inc. | 4.14B | 6.76% | 519,894 | 561.90M |
| 24 | CDNA | CareDx, Inc. | 3.72B | 4.07% | 415,119 | 458.09M |
| 25 | NEO | NeoGenomics, Inc. | 2.23B | 4.07% | 1,400,075 | 766.30M |
| 26 | WGS | GeneDx Holdings Corp. | 1.92B | 5.29% | 319,629 | 454.43M |
| 27 | PSNL | Personalis, Inc. | 1.71B | 1.01% | 679,711 | 69.67M |
| 28 | FRNM | Freenome, Inc. | 1.40B | 2.48% | 171,434 | 35.41M |
| 29 | OPK | OPKO Health, Inc. | 1.21B | -0.61% | 1,852,484 | 587.90M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.05B | 2.82% | 54,802 | 357.28M |
| 31 | MYGN | Myriad Genetics, Inc. | 601.64M | 4.49% | 964,995 | 806.60M |
| 32 | FLGT | Fulgent Genetics, Inc. | 559.11M | 0.49% | 83,032 | 323.93M |
| 33 | BDSX | Biodesix, Inc. | 227.06M | 1.22% | 106,459 | 102.94M |
| 34 | XGN | Exagen Inc. | 185.57M | 2.54% | 95,697 | 71.12M |
| 35 | BNR | Burning Rock Biotech Limited | 122.44M | 4.13% | 11,995 | 73.70M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 103.90M | 5.83% | 55,917 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 77.75M | 8.62% | 241,013 | 537.08K |
| 38 | PRPO | Precipio, Inc. | 35.22M | 1.68% | 3,439 | 27.20M |
| 39 | MDXH | MDxHealth SA | 18.56M | -0.10% | 267,081 | 114.02M |
| 40 | NDRA | ENDRA Life Sciences Inc. | 7.15M | -1.04% | 1,817 | - |
| 41 | XWEL | XWELL, Inc. | 6.59M | 1.79% | 14,737 | 28.28M |
| 42 | ADVB | Advanced Biomed Inc. | 4.99M | 10.62% | 19,039 | 127.64K |
| 43 | BIAF | bioAffinity Technologies, Inc. | 3.98M | 9.54% | 159,757 | 5.90M |
| 44 | ISPC | iSpecimen Inc. | 2.12M | 0.02% | 29,172 | 466.30K |